Spanish Software Stock News

Why Construcciones y Auxiliar de Ferrocarriles (BME:CAF) is on investors’ radar after Q1 earnings Construcciones y Auxiliar de Ferrocarriles (BME:CAF) has drawn fresh attention after reporting first quarter 2026 results, with sales of €1,158 million and net income of €40 million compared with €1,118 million and €36 million a year earlier. See our latest analysis for Construcciones y Auxiliar de Ferrocarriles. The earnings release has arrived alongside a clear upswing in sentiment, with a...

Soft earnings didn't appear to concern Secuoya, Grupo de Comunicación, S.A.'s ( BME:SEC ) shareholders over the last...

Indra Sistemas, S.A. ( BME:IDR ) just reported healthy earnings but the stock price didn't move much. Our analysis...

Investors may be wondering if Ferrovial stock still offers value after a strong run, or if the current price now reflects most of the potential upside. The share price last closed at €59.90, with returns of 2.5% over the past week, 0.2% over the past month, 8.2% year to date and 39.8% over the last year. The 3-year and 5-year returns stand at 118.5% and 167.8% respectively. Those returns sit against a backdrop of ongoing interest in infrastructure and construction companies. Investors are...

Market shock puts Distribuidora Internacional de Alimentación (BME:DIA) under intense scrutiny Distribuidora Internacional de Alimentación (BME:DIA) is under pressure after a very sharp collapse in its stock price reportedly wiped out over $1.2b in market value, putting its debt and liquidity position in focus for investors. See our latest analysis for Distribuidora Internacional de Alimentación. Even after the recent collapse, DIA’s latest share price of €39.65 sits against a 1 year total...

Repsol (BME:REP) is back in focus after reporting first quarter 2026 results, with sales of €15,502 million and net income of €929 million, while reaffirming its 2026 production guidance. See our latest analysis for Repsol. At a share price of €22.05, Repsol has a 90 day share price return of 31.29% and a year to date share price return of 34.37%, while the 1 year total shareholder return of 107.19% points to strong momentum built over a longer period. If this kind of move has you thinking...

Why the latest earnings update matters for Meliá Hotels International (BME:MEL) Meliá Hotels International (BME:MEL) released first quarter 2026 earnings, with sales of €308.1 million and revenue of €461.6 million, compared with €303.9 million and €444.5 million a year earlier. This earnings update gives you fresh information on how the hotel operator’s business is performing across its owned, leased, managed, and franchised properties in Spain, America, EMEA, and Asia. See our latest...

Iberdrola (BME:IBE) opened the first quarter of 2026 with earnings that showed lower sales, net income, and basic EPS compared with a year earlier. This shift naturally puts the stock under closer review. See our latest analysis for Iberdrola. The first quarter earnings setback comes after a softer 30 day share price return of a 4.07% decline and a modest 90 day share price gain of 0.46%. However, Iberdrola’s 1 year total shareholder return of 29.63% and 5 year total shareholder return of...

Latest FY 2025 earnings snapshot Amadeus IT Group (BME:AMS) has just wrapped up FY 2025 with fourth quarter revenue of €1.6b and basic EPS of €0.57, alongside net income of €247.5m, while on a trailing twelve month basis revenue stood at €6.5b and EPS at €3.04. Over recent periods the company has seen revenue move from €6.1b on a trailing basis at the end of Q4 2024 to €6.5b by Q4 2025, with EPS shifting from €2.87 to €3.04 over the same span, setting up the current release against...

Grifols (BME:GRF) opened Q1 2026 with revenue of €1.7b and net income of €73m, translating into basic EPS of €0.11, while the trailing 12 month figures show revenue of €7.4b, net income of €415m and EPS of €0.61. The company has seen quarterly revenue move across a range from €1.79b in Q1 2025 to €1.98b in Q4 2025, with basic EPS figures of €0.10 in Q4 2024 and €0.14 in Q4 2025 before landing at €0.11 this quarter. This puts margins and earnings quality at the center of the discussion for...

Despite posting some strong earnings, the market for Pharma Mar, S.A.'s ( BME:PHM ) stock hasn't moved much. We did...

Meliá Hotels International (BME:MEL) has just wrapped up FY 2025 with fourth quarter revenue of €469.9 million and basic EPS of €0.09, capping a trailing twelve month run of €2.1 billion in revenue and EPS of €0.77, alongside an 8.2% net margin compared with 7% a year earlier. Over the past few quarters, revenue has ranged from €444.5 million to €616.6 million with quarterly EPS between €0.03 and €0.34, giving you a clear view of how the earnings power has built through the year. With margins...

Laboratorio Reig Jofre (BME:RJF) has just wrapped up FY 2025 with fourth quarter revenue of €94.7m and net income of €3.1m, translating to Basic EPS of €0.04. The trailing 12 month figures show revenue of €336.7m and net income of €5.0m, with Basic EPS of €0.06. Over recent quarters, revenue has ranged from €72.8m to €94.7m, and quarterly net income has moved between a loss of €2.1m and a profit of €3.7m. This sets up a picture where investors are likely to focus on how consistent margins...

This article examines whether Fluidra at €19.23 is a bargain or fairly priced by exploring what the current market is implying about the stock's value. The share price has seen mixed returns, with a 3.3% decline over the last 7 days and a 10.0% decline over the past month, while the 3-year return sits at 22.9% and the 5-year return at a 31.4% decline. Recent coverage has focused on how Fluidra's share price performance compares with the broader machinery sector and how investor expectations...

Santander plans to retire the TSB brand from UK high streets after a takeover, folding TSB into Santander UK. The bank is set to close 26 UK branches as part of a wider shift toward digital banking services. The restructuring is aimed at cutting costs and reshaping Santander's UK presence, with direct effects on staff and customers. Banco Santander (BME:SAN) is acting on a material change to its UK footprint as it integrates TSB and accelerates branch closures. The stock trades at €10.466,...

Amadeus IT Group (BME:AMS) is back in focus after reporting first quarter 2026 results, with sales of €1,682.6 million and net income of €357 million, alongside ongoing buybacks and the planned IDEMIA Public Security acquisition. See our latest analysis for Amadeus IT Group. Despite the solid Q1 figures, the share price has had a mixed run, with a 1 month share price return of 5.46% and a year to date share price decline of 18.94%, contributing to a 1 year total shareholder return decline of...

Wondering whether Grifols at around €9.16 a share is offering genuine value or just looks cheap on the surface? This article walks through what the current price might actually be telling you. The stock has returned 2.2% over the last week and 1.2% over the last month, while the year to date return sits at an 18.2% decline and the 1 year return is 13.3%, set against a 16.1% decline over 3 years and a 59.8% decline over 5 years. Recent headlines around Grifols have focused on its balance...

Shareholders appeared unconcerned with Logista Integral, S.A.'s ( BME:LOG ) lackluster earnings report last week. We...

Endesa (BME:ELE) opened Q1 2026 with revenue of €5.8b and basic EPS of €0.70, setting the tone for how investors will read the latest move in profitability. The company reported quarterly revenue of €5.8b in both Q1 2025 and Q1 2026, while EPS increased from €0.55 to €0.70 over the same period, providing a clearer view of how earnings are tracking against a broadly stable top line. With trailing net margins above last year and earnings growth running ahead of revenue, this update places...

Laboratorios Farmaceuticos Rovi (BME:ROVI) has capped FY 2025 with fourth quarter revenue of €218.4 million and basic EPS of €0.83, while trailing 12 month figures show revenue of €743.5 million and EPS of €2.75 alongside net income of €140.4 million. The company has seen quarterly revenue move from €199.1 million in Q4 2024 to €218.4 million in Q4 2025, with net income rising over the same period from €23.4 million to €42.7 million, setting up a story where margins and earnings power sit...

Earnings snapshot and context GMP Property SOCIMI (BME:YGMP) has released its H1 2025 figures, reporting total revenue of €57.2 million and basic EPS of €5.97, alongside a very large 12‑month profit swing that management attributes in part to a €138.0 million one‑off gain. Over recent half‑year periods, the company reported revenue of €49.2 million and EPS of €3.74 in H1 2024, compared with €57.2 million and EPS of €5.97 in H1 2025, while H2 2023 revenue was €49.8 million with an EPS loss of...

Q1 earnings snapshot and why it matters for Ebro Foods (BME:EBRO) Ebro Foods (BME:EBRO) opened the year with first quarter sales of €755.48 million versus €791.96 million a year earlier, while net income reached €52.95 million compared with €50.3 million. This combination may reshape how you think about the stock. See our latest analysis for Ebro Foods. The share price sits at €18.28, with a 30 day share price return of a 2.66% decline and a year to date share price return of a 0.98% decline...

The Q1 2026 earnings call for Fomento de Construcciones y Contratas (BME:FCC) on April 30 has put fresh attention on the stock, as investors reassess recent returns alongside the company’s latest operating update. See our latest analysis for Fomento de Construcciones y Contratas. The Q1 2026 earnings call appears to have been a key catalyst for the recent move, with the 1 day share price return of 1.63% and 7 day share price return of 2.00% helping the stock edge higher. The 1 year total...

First quarter results and why they matter for Viscofan (BME:VIS) shareholders Viscofan (BME:VIS) has just reported first quarter 2026 results, with sales of €305.33 million versus €307.64 million a year earlier, while net income came in at €33.68 million compared with €31.36 million. See our latest analysis for Viscofan. The first quarter update comes after a steady share price run, with a 90 day share price return of 8.59% and a 12.83% year to date share price return from the current €60.7...